Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Spain under new pressure to back embryo work:

This article was originally published in Clinica

Executive Summary

The Spanish government has come under renewed pressure to allow embryonic stem cell research. James Shapiro, of the Center for Clinical Islet Transplantation, at the University of Alberta, in Edmonton, Canada, has joined the debate, praising the work being led by Bernat Soria, director of the bioengineering institute of the Miguel Hernandez university, in Elche, Spain, into the synthesis of pancreatic beta cells, responsible for producing insulin. Dr Shapiro voiced his support for Dr Soria at the annual congress of the Spanish diabetes society, held in Ca diz earlier this month. Dr Soria has said he will be forced to continue his work abroad, in "an undisclosed country", according to statements made to El Pais. Some 2,000 cadaveric pancreases become available in the US every year, while there are about one million type-1 diabetes patients in the US alone, according to the New York-based Juvenile Diabetes Research Foundation.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT065743

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel